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ABSTRACT 
Motivation: Fine mapping is a widely used approach for identifying the 
causal variant(s) at disease-associated loci. Standard methods (e.g. multiple 
regression) require individual level genotypes. Recent fine mapping 
methods using summary-level data require the pairwise correlation 
coefficients () of the variants. However, haplotypes rather than pairwise , are the true biological representation of linkage disequilibrium (LD) 
among multiple loci. In this paper, we present an empirical iterative method, 
HAPlotype Regional Association analysis Program (HAPRAP), that 
enables fine mapping using summary statistics and haplotype information 
from an individual-level reference panel.  
Results: Simulations with individual-level genotypes show that the results 
of HAPRAP and multiple regression are highly consistent. In simulation 
with summary-level data, we demonstrate that HAPRAP is less sensitive to 
poor LD estimates. In a parametric simulation using Genetic Investigation 
of ANthropometric Traits (GIANT) height data, HAPRAP performs well 
with a small training sample size (N<2000) while other methods become 
suboptimal. Moreover, HAPRAP’s performance is not affected 
substantially by SNPs with low minor allele frequencies. We applied the 
method to existing quantitative trait and binary outcome meta-analyses 
(human height, QTc interval and gallbladder disease); all previous reported 
association signals were replicated and two additional variants were 
independently associated with human height. Due to the growing 
availability of summary level data, the value of HAPRAP is likely to 
increase markedly for future analyses (e.g. functional prediction and 
identification of instruments for Mendelian randomization). 
Availability: The HAPRAP package and documentation are available 
online: http://apps.biocompute.org.uk/haprap  
1 INTRODUCTION  
                                                 
 
Genome-wide association studies (GWAS) have identified 
thousands of single nucleotide polymorphisms (SNPs) associated 
with human complex traits and diseases (Hindorff et al., 2009; 
Manolio, 2010). To increase the power to detect small genetic 
effects associated with common complex traits, meta-analysis of 
multiple GWAS studies have also been conducted including blood 
lipids (Teslovich et al., 2010), Electrocardiographic (ECG) traits 
(Arking, et al., 2006; Pfeufer, et al., 2009; Newton-Cheh et al., 
2009; Marroni et al., 2009; Gaunt et al., 2012) and human height 
(Wood, et al., 2014) amongst others.  
When a plausible hit has been identified within a GWAS, the 
challenge becomes one of determining the independent potentially 
causal SNP signals from a background of many correlated variants 
within the LD block.  A common strategy adopted is to take the top 
association signal to represent the association in a genomic region. 
However, this design does not take into account the possibility of 
multiple causal variants within a region, which will result in an 
underestimation of the total variation that could be explained at a 
locus (Yang et al., 2012).   Statistical methods are available to 
identify independent hits; however these methods either require 
access to individual level data, or rely on pairwise LD estimates 
when summary statistics are used.   
Conditional analysis is time consuming when individual level 
genotype data from several cohorts needs to be analyzed separately 
and then combined in meta-analysis (Zheng et al., 2013). Providing 
the pairwise LD structure is consistent in samples from the same 
ethnic group (Ke et al., 2004), there are two approximate 
conditional analysis methods that can effectively use GWAS 
summary data: GCTA conditional and joint effect analysis (COJO) 
(Yang et al., 2012) and SSSRAP (Zheng et al., 2013).  
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2 
COJO is a state-of-the-art method extending the scope of multiple 
regression to summary-level meta-analysis. COJO estimates the 
approximate joint SNP effects from summary statistics in a 
meta-analysis and LD information from an appropriate reference 
sample. SSSRAP is a numerical and graphical approach that 
transforms the marginal SNP effect of a sentinel SNP to the joint 
SNP effect of a test SNP through a 2×2 SNP-haplotypes matrix.  
These existing approximate conditional analysis methods use 
pairwise correlation coefficients (r2) between SNPs to represent LD 
structure in each associated region. However, when considering 
regions with three or more causal variants, utilizing allele 
frequencies and pair-wise LD correlation may lose LD information. 
Three-locus systems may place additional constraints on the 
maximum and minimum values for the pair-wise LD terms 
(Robinson et al., 1991). Haplotypes, which represent combinations 
of co-inherited alleles within the same chromosome, are a more 
biologically correct way to represent LD among multiple loci. Fine 
mapping using haplotypes will pick up the LD information that is 
not detected using pairwise LD measures.  
To aid the ‘missing LD information’ problem, we propose an 
empirical iterative method “HAPlotype-based Regional Association 
analysis Program” (HAPRAP) to improve the accuracy of 
approximate conditional analysis using GWAS summary data. The 
important difference between HAPRAP and COJO is that the 
former estimates the joint SNP effects by using haplotypes (rather 
than pair-wise LD) estimated from a reference sample. We use both 
simulations and real-data from the British Women’s Heart Health 
Study (BWHHS) (Lawlor et al., 2003) to show that HAPRAP 
outperforms COJO on a range of performance measures. We 
applied the method to group-level QTc interval data from the 
UCLEB meta-analysis (Shah et al., 2013), with the haplotype 
information estimated from imputed genotype data from the 
BWHHS; and human height from the GIANT meta-analysis (Wood 
et al., 2014), with the haplotype information estimated from the 
Avon Longitudinal Study of Parents and Children (ALSPAC). Both 
cases suggest that HAPRAP has increased power for fine mapping 
compared to COJO. We extended HAPRAP to binary phenotypes 
and we illustrate this with an example of meta-analysis for 
gallbladder disease (GBD) SNP hits (Rodriguez et al., 2015).  
2 METHODS 
2.1 Overview of the methodology 
We aim to combine summary level statistics with the full information from 
haplotypes (rather than using the traditional pairwise LD approach) to fine 
map genetic regions. Our algorithm iteratively updates haplotype effects 
based on haplotype frequencies and observed marginal SNP effects from 
meta-analyses to estimate the approximate joint SNP effect. This approach 
allows researchers to conduct conditional analysis more accurately without 
access to individual level genotypes. 
2.1.1 Theory 
The haplotype-based approach we propose in this manuscript is closely 
related to a single regression model. In a single regression model, we treat 
the major allele as the baseline allele; and the minor allele as the effect allele. 
The marginal SNP effect refers to the effect estimate from an outcome Y 
regressed on a single SNP (i.e. the allelic effect from a simple linear 
regression model). The joint SNP effect, which we aim to estimate, refers to 
the SNP effect obtained from Y regressed on multiple SNPs within the 
region. The joint SNP effect is adjusted for the correlation with surrounding 
SNPs, whereas the marginal SNP effect is not. 
A simple extension of the single regression model to multi-locus data is to 
integrate two popular haplotype-based analysis strategies together: 1) 
dichotomise haplotypes into two groups (Lin et al., 2006); and 2) treat each 
group as a bivariate allele (Purcell S et al., 2007 A).  
Assume we obtain a SNP by haplotype matrix	, with , = 0	or	1, from 
a sample population, we split existing haplotypes into two groups to 
estimate the joint effect of SNP j: 
 
  =  ∶ 	, = 1		 =  ∶ 	, = 0 
 is the set of haplotypes containing the effect allele of SNP j; and,	 is 
the set of haplotypes containing the baseline allele of SNP j. For example, 
for SNP1 in Figure 2,  is the set of haplotypes from Haplotype 5 to 
Haplotype 8, whereas 	is the set of haplotypes from Haplotype 1 to 
Haplotype 4. We also split the haplotype frequencies into two groups based 
on the relevant haplotypes  and . 
We then define the estimated marginal SNP effect of a SNP j, U as: 
 			U 	= 	, 	−	,	; 	 ∈  		and		 ∈  																								(1) 
 
where ,  (or , 	) is the average of the additive effect over the set of 
haplotypes  	(or	) . These additive haplotype effects can be 
transferred to joint SNP effects using a generalised inverse matrix approach. 
This extension is applicable to both linear and logistic regression models.  
2.1.2 HAPRAP algorithm for estimating the joint SNP effect 
As individual-level genotype data is usually not publicly available for 
GWAS meta-analysis, we cannot estimate haplotype effects by conducting a 
haplotype-based association analysis. Thus, we use an iterative method to 
estimate the haplotype effects from marginal SNP effects. The iteration 
involves four steps (Figure 1):  
Step 1: Setting initial values for joint SNP effects and haplotype effects 
transformation 
Step 2: The marginal SNP effects estimation 
Step 3: The haplotype effects adjustment 
Step 4: Convergence and the generalised inverse matrix approach 
Table 1 provides details of the notation used in describing our method.  
Table 1. Notation of HAPRAP. Column “Par.” lists the parameters used in 
HAPRAP 
Par.  Description  &	 × 	(  SNP by haplotype matrix, with , = 0 or 1，with 0 being 
the baseline allele of SNP j, 1 being the effect allele of SNP j.   the set of haplotypes containing the effect allele of SNP j.   the set of haplotypes containing the baseline allele of SNP j.   the set of haplotype frequencies containing the baseline allele of SNP 
j.   the set of haplotype frequencies containing the baseline allele of SNP 
j.  ) (	 × 	1 vector of observed marginal SNP effects from GWAS / 
meta-analysis *(+) ,(-) (	 × 	1 vector of random initial joint SNP effects.  (	 × 	1 vector of the estimated marginal SNP effects in the ./0
iteration. 
 at U
niversity Library on Septem
ber 20, 2016
http://bioinform
atics.oxfordjournals.org/
D
ow
nloaded from
 
3 
1(-) &	 × 	1 vector of the estimated haplotype effects of in the ./0
iteration. 2(-) 
 
the SNP with the greatest deviation between the observed marginal 
SNP effect and the estimated marginal SNP effect in the g iteration. *(-) (	 × 	1 vector of the estimated joint SNP effects in the ./0 iteration. 
Fig 1. Schematic Diagram of HAPRAP. 
 
Step 1. Setting initial values for joint SNP effects and haplotype effects 
transformation: The algorithm starts with setting up a random set of initial 
joint effects for SNPs, *(+) 
Assuming that haplotypes (and haplotype frequencies) in the reference 
panel are the same as those in the GWAS meta-analysis, we estimate the 
haplotype frequencies  and the SNP by haplotype matrix  from the 
reference panel.  
Assuming an additive linear model, the initial estimated haplotype effect 1(+) is the matrix product of  and *(+) (Figure 2): 
 *(+) = 1(+)																																																							(2) 
Fig 2. The SNP by haplotypes matrix for HAPRAP. The iteration of 
HAPRAP is built based on a matrix summarizing the haplotypes and 
haplotype frequencies for a certain population. “0” in the matrix means the 
haplotype contains the baseline allele for the relevant SNP, whereas “1” 
means the haplotype contains the effect allele for the relevant SNP. The 
small arrow (from left to right) is the marginal SNP effects estimation step. 
The large arrow (from right to left) is the haplotype effects adjustment step. 
 
 
Step 2. Marginal SNP effects estimation:  
As mentioned in Equation (1), we define the marginal SNP effect as the 
difference between the sums of the additive effects of the two sets of 
haplotypes  	and	. 
Thus, for the g iteration, where g = {0...G}, the marginal SNP effect of SNP 
j, U(-), is estimated by counting the difference between the two groups of 
haplotype effects, Z,(-)  and Z,(-) , and standardised by the relevant 
haplotype frequencies,  and : 
 
U(-) =	 1∑ ∈6 7 8 Z,(-)∈6 9−	
1∑ ∈6 7 8 Z,(-)∈6 9						(3) 
 
We tested the reliability of equation (3) by a simulation and found that 
given any set of joint SNP effects, application of equation (3) never 
generated nonzero effect estimates for SNPs that were simulated to have 
truly null effects (Text S2).    
 
Step 3. Haplotype effects adjustment: the adjusted marginal SNP effects 
for iteration g, ,(-) are compared to the observed marginal SNP effects, ). Reconciling the difference between ,(-) and ) is important because it 
equates the marginal SNP effects observed from the meta-analytic data with 
those that would arise under the distribution of haplotypes in the reference 
panel. The SNP with the greatest deviation, denoted 2(-), is adjusted for 
the next iteration g+1, the other SNP effects remain the same: 
 
U(-:) =				 ;U(-) −O= 		where	 = 	 2(-)U(-)	where		 A 2(-) 																									(4) 
 
Then the haplotype effect 1(-:) will be adjusted based on the change of 
U(-:). For haplotype k, we get: 
Z(-:) = Z(-) C U(-)m, 	where	 = 2(-)																		(5) 
Step 4. Convergence and the generalised inverse matrix approach: 
After the estimated marginal SNP effects, ,(-) converge to within 10 
decimal places of the observed SNP effects, ), we stop the iteration. The 
joint SNP effects, *(-), is estimated using the generalised inverse matrix 
approach:  
 F1(-) = *(-)																																																													(6) 
 
2.2 Estimating standard errors of the estimated joint SNP 
effects and testing SNP significance using parametric 
bootstrap 
We estimate the standard errors (SE) of the estimated joint SNP effects 
using a bootstrap approach so that we can apply the stepwise elimination 
using the joint p-value in the next step.  
Pre-test of SNP significances: Generating bootstrap standard errors can 
use computational resources intensively. To improve computational 
efficiency, we first pre-test the significance of the candidate SNPs using the 
estimated joint SNP effects *(-) and the standard errors of the observed 
marginal SNP effects (since the uncertainty of the effect of a given SNP is 
larger in a multivariate model than that in a single SNP model). SNPs with 
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the highest p value will be step-wise eliminated from the model until all 
SNPs reach the p value threshold we set.  
If two or more SNPs remain in the model after the pre-test using SEs from 
single locus regression, we then estimate the standard errors of HAPRAP 
betas of these SNPs using a simulation based HAPRAP program 
(simHAPRAP) (Figure S1). The simHAPRAP program starts with 
simulating a population with sample size equal to the total number of 
participants in the meta-analysis. Genotypes for each individual are 
generated based on the haplotypes and haplotype frequencies. Quantitative 
phenotypes are simulated from a normal distribution with mean equal to 
zero and SE equal to the observed standard deviation of the phenotype; 
whereas binary phenotypes are simulated from a binomial distribution 
which matches the observed probability of cases. A weighted genetic risk 
factor is used as the total genetic effect on the trait (Figure S1).   
We repeat the simHAPRAP procedure 2000 times. The SE of the betas over 
the 2000 replications are used as the standard errors of the HAPRAP betas 
(defined here as simHR SE).   
Stepwise backwards elimination: t-test p values are calculated using 
HAPRAP betas and simHAPRAP SEs. We backward eliminate the SNPs 
with the highest p values until all SNPs in the model reach a pre-set p value 
cut-off.  
HAPRAP availability: The HAPRAP software and a web-based 
instruction manual (developed using HTML and CSS) are available at 
http://apps.biocompute.org.uk/haprap. 
2.3 Sample Datasets 
The real cases and simulated datasets we used for this analysis are 
explained in Text S3. 
2.4 Simulation framework and empirical comparison 
Firstly, we simulated a pool of 100000 individuals (details in Text S3) and 
performed a series of simulations to test the influence of LD structure and 
sample size of reference panel. For each model explained in Text S3 and 
Table S1, we applied HAPRAP and COJO to the summary statistics and the 
genotypes of a specific reference panel. We also applied multiple regression 
using individual-level phenotypes and genotypes from the reference panel. 
For each method, the mean and standard deviation of the joint SNP effect 
were estimated 1000 times. In addition, multiple regressions on the 100000 
individuals were conducted (Text S3) and the resulting joint SNP effects 
were set as the gold standards. Mean square error (MSE) of the gold standard 
effect was used to measure the accuracy of each method. 
Secondly, we performed a parametric simulation to test the influence of the 
sample size of a meta-analysis. The GIANT height meta-analysis data were 
used as the basis of this simulation (Wood et al., 2014). We selected 20 
nearest SNPs from the ACAN region. ALSPAC pre-phased haplotypes of 
8263 unrelated children were used to build a genotype pool for 253288 
individuals. We randomly selected 100000, 50000, 10000, 5000, 2500, 1750 
and 1000 individuals from the pool, comparing the performance of HAPRAP 
and COJO using multiple regression as the gold standard. 1000 replications 
were processed to estimate the MSE and SD of the MSE.  
Thirdly, as an empirical comparison between HAPRAP and COJO, we 
explored these methods using real data from the BWHHS and the 1000 
Genomes project. Details of the performance comparisons are explained in 
Text S4.  
2.5 Case study for quantitative traits: GIANT height 
We firstly applied HAPRAP to two meta-analyses. Details of these two 
case studies are explained in Text S5. We further applied HAPRAP to 
summary-level data from the GIANT height meta-analysis (sample size 
253288). The pre-phased haplotypes of 8263 unrelated children from 
ALSPAC were used as the reference panel. Three genomic regions with 
more than one robust independent association signal were selected (Wood 
et al., 2014). All SNPs within these regions were selected (782 SNPs for 
ACAN, 1477 SNPs for ADAMTS17 and 1936 SNPs for PTCH1).  
3 RESULTS 
3.1 Simulation and empirical comparison 
Firstly, we fixed the sample size of the meta-analysis (N=100000) 
and compared the performance of HAPRAP and COJO across 
different LD structures and different sample sizes of reference 
panel using a simulation data set (details in Text S3). As shown in 
Table S2, HAPRAP outperformed COJO under a variety of LD 
structures and was less sensitive to poor LD estimation. 
Fig 3. Performance 
Comparison between 
HAPRAP and COJO 
in one of the 3-SNPs 
Model. MSE is mean 
square error of 
HAPRAP (or that of 
GCTA) compare to 
joint effect from 
multiple regression 
mode. X-axis is the 
number of individuals 
in the reference panel 
on a log scale, which 
is equivalent to 
sample size of 10000, 
5000, 1000, or 500 
respectively. In this 
simulation, SNP1 is a 
signal with a  joint 
effect of 1, SNP2 is a 
bystander SNP with 
no effect, SNP3 is a 
secondary SNP with a 
joint effect of 0.3,  
between SNP1 and 
SNP2 was 0.8,  
between SNP1 and 
SNP3 was 0.5.  
 
In the 2-SNP models with one causal SNP and one non-effect SNP, 
HAPRAP was slightly (up to 29%) more accurate than COJO 
across 16 models (Figure S2A and Table S2A). Both methods 
performed well when the sample size of the reference panel was 
larger than 5000. When the sample size of the reference panel was 
limited to 500 to 1000, HAPRAP started to outperform COJO. On 
the other hand, considering the influence of LD structure, 
HAPRAP was up to 54% more accurate than COJO when LD 
between the two SNPs was extremely high (=0.9). 
In the 3-SNP models with two causal SNPs and one non-effect 
SNP (Figure 3 and Figure S2B), both methods performed relatively 
well when the sample size of the reference panel was larger than 
5000 (although with more errors compared to the 2-SNP models). 
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However, both methods struggled to eliminate the non-effect SNP 
when the sample size of reference panel is less than 1000 and LD 
was very high amongst three SNPs. However, in a more realistic 
LD range ( between each pair of SNPs from 0.1 to 0.5) and with 
a small reference sample size (N=1000), HAPRAP was, on average, 
63% more accurate than COJO (Table S2B).  
We demonstrated in this simulation that, when individual-level 
data is extremely limited, HAPRAP (using summary level data and 
a reference panel with a small number of individuals) is a better 
option than applying multiple regression to the reference panel 
with limited sample size (Figure S2C and Table S2). 
Secondly, in the parametric simulation using GIANT height data, 
we assumed perfect LD estimation and only consider the influence 
of sample size of the meta-analysis. As shown in Figure 4 and 
Table S3, HAPRAP and COJO were close to optimal (Text S6 
explains the reason COJO is not perfectly optimal in this situation) 
when the sample size of the meta-analysis was large (N≥10000). 
When the training sample size was between 1750 and 5000, 
HAPRAP’s mean square error was still under 0.1 while COJO 
became suboptimal.  
Fig 4. Performance comparison of HAPRAP and COJO using 
parametric simulation of 20 SNPs from GIANT height 
meta-analysis. MSE is the mean square error of the method 
compare to multiple regression. X-axis is the number of 
individuals in the meta-analysis in Log scale. Horizontal line is the 
threshold line of mean square error of 0.1.  
 
Thirdly, we utilised individual-level data of ~2000 BWHHS 
individuals on a total of 115 SNPs to compare the accuracy of 
HAPRAP (haplotypes phased by both SHAPEIT (O. Delaneau, et 
al., 2012) and PLINK) and COJO using multiple regression as the 
gold standard (Table S4). The details of the comparison can be 
found in Text S4. In summary, the comparisons suggested that 
HAPRAP was comparable to multiple regression when the 
individual-level genotypes are available for the entire cohort. In 
addition, HAPRAP was on average 10.86% more accurate than 
COJO when the sample size of the reference panel was extremely 
limited (Sample size < 200). 
3.2 Case study: GIANT meta-analysis of height 
We further analysed three genomic regions reported to be associated 
with human height by the GIANT consortium. The original fine 
mapping analyses were processed using COJO, resulting in 18 
associated SNPs with P value < 5×10-8 at these 3 loci (Wood et al., 
2014). Here, we applied HAPRAP to a total of 4195 SNPs using 
8263 unrelated ALSPAC children as a reference panel. The allele 
frequencies of GIANT and the ALSPAC children were quite similar 
(Table S5). As shown in table 2, HAPRAP replicated all 18 
previously reported association signals at these 3 loci (Table 2). 
Moreover, HAPRAP identified two novel signals, rs1529889 (an 
intronic variant in ADAMST17 with joint effect of 0.019) and 
rs357564 (a missense variant in PTCH1 with joint effect of -0.034), 
independently associated with height, (Table 2). As shown in Table 
S6, these two SNPs are in low LD with independent SNPs in the 
same genomic region. 
Surprisingly, when we applied COJO to the same data using a 
different reference panel (ALSPAC instead of ARIC), only 16 SNPs 
were significantly associated with height, leaving 2 SNPs 
unselected (Table S5). 
We also conducted two cases studies of gallbladder disease and QTc 
intervals. Details of these cases studies are in Text S5.  
 
Table 2. Summary of 20 associated SNPs at 3 loci for height with P < 5×10−8 
in the HAPRAP step-wise model selection analysis using the ALSPAC 
cohort as a reference sample for LD  
SNP 
COJO-GIANT  HAPRAP 
BETA P-value BETA P-value 
rs1348002 0.020  1.5x10-10 0.018  2.8x10-09 
rs11633371 0.024  2.1x10-15 0.028  4.8x10-20 
rs16942341 -0.114  3.0x10-29 -0.122  3.4x10-34 
rs2280470 0.031  5.5x10-21 0.032  1.9x10-25 
rs3817428 0.022  2.6x10-09 0.019  1.2x10-08 
rs2238300 -0.018  1.6x10-09 -0.020  3.8x10-11 
rs2573625 0.030  3.7x10-22 0.025  2.4x10-15 
rs1529889 Unselected Unselected 0.019  6.4x10-10 
rs4246302 -0.027  1.4x10-16 -0.028  1.4x10-17 
rs4548838 0.034  9.1x10-30 0.033  1.4x10-28 
rs7170986 -0.019  1.1x10-08 -0.018  4.5x10-08 
rs8042424 -0.022  5.1x10-10 -0.022  2.2x10-10 
rs1257763 0.071  9.4x10-14 0.078  2.2x10-12 
rs12347744 -0.056  2.8x10-20 -0.039  1.7x10-19 
rs357564 Unselected Unselected -0.046  3.9x10-13 
rs4448343 -0.035  1.1x10-28 -0.035  2.0x10-17 
rs1329393 0.038  1.4x10-15 0.034  5.1x10-13 
rs817300 -0.070  2.2x10-23 -0.085  4.8x10-16 
rs10990303 0.032  1.4x10-19 0.036  5.4x10-18 
rs7870753 -0.045  1.7x10-37 -0.043  1.3x10-30 
BETA and P-value under COJO-GIANT refer to the joint SNP effect and its 
P-value presented in the GIANT height paper. BETA and P-value under 
HAPRAP are the joint SNP effect and its P-value for HAPRAP. “Unselected” 
means the SNP was not selected by COJO in the step-wise selection. The 
comparison details are presented in Table S5. 
4 DISCUSSION 
Meta-analysis summary association statistics are becoming more 
and more widely available to the scientific community 
(Bulik-Sullivan et al., 2015A). Several genetic analysis methods 
have been developed to exploit these resources (using summary 
rather than individual-level data), for example, LD score regression 
(Bulik-Sullivan et al., 2015 A & B; Finucane et al., 2015), 
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Gaussian imputation (Pasaniuc et al., 2014) and two-sample 
Mendelian randomization (Pierce and Burgess, 2013).  
In this paper, we introduced a novel approach for statistical fine 
mapping using meta-analysis summary statistics. The proposed 
method (HAPRAP) uses haplotypes to represent LD structure 
among multiple variants in a region. Using haplotypes has four 
significant advantages compared to existing conditional analysis 
methods that utilise pairwise correlation coefficients (r2) between 
SNPs (such as COJO (Yang et al., 2012), SSSRAP (Zheng et al., 
2013)): 
1. It considers all loci simultaneously, rather than pairwise, thus 
it is less susceptible to poor LD estimates that occur if the 
reference LD structure does not closely match the 
populations studied in the GWAS data. 
2. It is more accurate than COJO when the sample size of the 
meta-analysis is limited (e.g. N ≤ 5000).  
3. It is more accurate and powerful for regions with three or 
more independent signals. Compared to Bayesian fine 
mapping methods such as PAINTOR (Kichaev et al., 2014, 
2015), CAVIAR (Hormozdiari et al., 2014) and CAVIARBF 
(Chen et al., 2015), HAPRAP does not require the user to 
specify the number of causal variants. This can impair the 
performance of CAVIARBF for cases where there are 
multiple causal variants (Kichaev et al., 2014). We observed 
a power improvement in our case study of human height 
(e.g. with 3+ independent signals within each associated 
region). 
4. It is more accurate when analysing rare variants (i.e. MAF < 
0.01) than other methods using pair-wise LD. 
Our empirical demonstration using the 1000 Genomes Project data 
comparison is meaningful in three aspects: Firstly, high quality 
haplotypes data, which is used by HAPRAP, are now widely 
available and should have already been pre-phased within 
large-scale consortiums/cohorts such as the abovementioned 1000 
Genomes Project and ALSPAC. Secondly, for researchers without 
individual-level genotype data, our method can give researchers a 
general profile of the potentially multiple associated SNPs in the 
region(s) of interest using the public available 1000 Genome 
Project data, although the errors of using the 1000 Genomes 
Project data as a reference panel were relatively large since the 
sample size is currently small. As more open access phased 
haplotype data becomes available with the publication of projects, 
such as UK10K (UK10K consortium, 2015), HAPRAP’s accuracy 
advantage against COJO will increase. Thirdly, HAPRAP’s 
performance advantage will be more apparent for GWAS studies 
with relatively smaller sample sizes, such as association analyses 
of DNA methylation with expensive or high-dimensional 
phenotypes (eg gene expression and methylation data (Shi et al., 
2014; Gaunt et al., 2015). 
In the case study using summary statistics of GIANT data (Wood 
et al., 2014), we identified two additional variants, rs1529889 and 
rs357564, independently associated with human height. These 
findings could have been caused by the greater sample size of the 
reference panel using ALSPAC (8263) compared to ARIC (6654). 
Rs357564 is a missense variant within PTCH1 and rs1529889 is an 
intronic variant within ADAMST17. Rs357564 is predicted to be 
“functional” by the prediction tool FATHMM (Shihab et al., 2015). 
and was reported to be associated with oral clefts, basal cell 
carcinoma and ameloblastoma (Begnini et al., 2010; Carter et al., 
2010; Farias et al., 2012.).  
Rare variants are on average younger than common variants 
(Mathieson and McVean, 2014) and are more likely to be 
represented by longer haplotypes. Since HAPRAP uses haplotypes 
and COJO uses pairwise LD, we show HAPRAP may have a 
theoretical advantage over COJO in rare variant analyses. We 
performed a simulation for two SNPs with MAFs near 0.08 (Table 
S7) and HAPRAP’s accuracy was higher than COJO in all 
conditions. Moreover, we highlighted a rare variant in 
Apolipoprotein B (APOB), rs41288783, as a proof-of-concept 
using real data (Table S8). This SNP had a MAF of 0.0018 in 
BWHHS individuals. The HAPRAP estimate (beta=0.705) is very 
close to the gold standard results (beta: 0.731), whereas the COJO 
estimate is considerably different from the gold standard (beta: 
0.449).  
We recommend using pre-phased haplotypes as HAPRAP input. 
For a cohort without haplotype data, we recommend users phase 
haplotypes using tools such as SHAPEIT (O. Delaneau, et al., 
2012), BEAGLE (Browning and Browning, 2009), IMPUTE2 
(Howie et al., 2009) and MACH (Li et al., 2010) rather than 
PLINK (Purcell et al., 2007 B). PLINK haplotype phasing function 
uses an E-M algorithm, which is only accurate and fast when a 
small number of SNPs (N<10) are included (Browning and 
Browning, 2011).  
We also suggest controlling for collinearity before utilising 
HAPRAP. If SNPs with very high variance inflation factor (VIF) 
values are included, HAPRAP (and other tools) will return 
extremely large betas for a pair of SNPs. Practically, it is necessary 
to remove SNPs with VIF higher than seven before applying 
HAPRAP.  
HAPRAP requires more time than COJO to finalise the step-wise 
elimination process. There are several reasons: firstly, phasing 
haplotypes is time consuming; secondly, it is time consuming to 
determine the standard errors of the joint SNP effects using our 
bootstrap method (simHAPRAP). However, the whole process 
does not usually take more than an hour.  
HAPRAP was originally designed for regional fine mapping, so it 
is more suitable for moderately small numbers of markers and 
computationally very fast when the number of SNPs in each test is 
10 or fewer. To fit the HAPRAP framework to fine map the whole 
genome, we recommend splitting regions with large numbers of 
SNPs into smaller chunks (up to 20 SNPs in each chunk) before 
running HAPRAP. In the GIANT height example, we split the 
genomic regions based on recombination hotspots, since LD 
patterns are directly related to the underlying recombination 
process, which is a more reasonable option compared to the 
physical distance used by COJO. This can help reduce the run time 
of HAPRAP substantially.  
Algorithms are often used effectively where the biological model is 
well understood, but the statistical model is too complex to 
generalize to all scenarios. For instance, a recent fine mapping 
method, probability identification of causal SNPs (PICS), used an 
empirical constant in its core algorithm to estimate the expected 
mean of the association signal at a SNP (Farh et al., 2015). 
HAPRAP interprets a complex biological concept, haplotype 
effects, using a simple idea stemming from allelic association 
analyses and extending it to the haplotype model. The side effect is 
that an asymptotic analysis of convergence may not be possible, 
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thus we cannot exclude the possibility that HAPRAP will not 
converge in some situations. However, in the hundreds of 
thousands of simulations and real case examples we have tested, 
we did not find any situation where HAPRAP did not converge.  
In a recent review paper (Spain et al., 2014), fine mapping methods 
were classified into two groups: 1) methods for triaging variants 
based on p-values or LD with the lead SNP, which includes classic 
conditional analysis and approximate methods such as COJO and 
HAPRAP; 2) Bayesian methods that assign posterior probabilities 
of membership in causal models to each SNP, such as PAINTOR, 
CAVIAR, CAVIARBF and the most recent software, FINEMAP 
(Benner et al., 2016). Compared to CAVIARBF, FINEMAP used a 
new search algorithm and so is much faster and overcomes the 
limitation of situations where there are more than three causal 
variants in a genomic region. In addition, for the above Bayesian 
methods (with the exception of FINEMAP), a parameter must be set 
for the number of causal SNPs (Spain et al., 2014). It has been 
shown that specifying this value to one can impair performance in 
cases where there are two or more causal variants (Kichaev et al., 
2014). Based on this we consider HAPRAP and these Bayesian 
methods as complementary. It would be interesting to explore the 
potential of integrating the HAPRAP methods with these Bayesian 
algorithms to develop more powerful fine mapping methods in the 
future. 
In conclusion, with increasing numbers of publicly available 
meta-analysis summary statistics, the value of HAPRAP is likely to 
be demonstrated in four ways: 1) for fine mapping both common 
and rare variants and identifying additional variants independently 
associated with complex traits; 2) it can be used as a variable 
selection method for two-sample Mendelian randomization; 3) to 
build genome-wide allelic scores of biological intermediates for 
mining the phenome (Evans et al., 2013); 4) to provide a solid 
platform for the functional annotation of casual variants using 
prediction tools such as FATHMM (Text S7).  
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